Daily Coverage | SGO

Alexa Kanbergs, MD-ScM, MS

Streamlining Surgery to Enhance Outcomes

Rise of de-escalation trends requires educational shift to transform disease management.

Linda Duska, MD, MPH

Pembrolizumab Plus Chemotherapy Regimen Yields Clinically Positive Outcomes for Treatment of Locally Advanced Cervical Cancer

Sgo Annual Meeting Saturday Photo By Fwc Awards

FWC Research & Grant Recipients

San Juan, Puerto Rico

Save the date for SGO 2026 Annual Meeting on Women’s Cancer

Get to Know SGO’s Incoming President

Sgo Annual Meeting Friday Photo By Nick Klein Awards

SGO and FWC Leadership Award Winners

Twelve individuals are recognized for their work in research and service.

audience shot

A Potential New Detection Tool for Invasive Cervical Cancer

Circulating human papilloma virus DNA shows promise as a universal biomarker.

View the current issue of Gynecologic Oncology

View the current issue of Gynecologic Oncology

Ginger Gardner, MD, FACOG

Empowering Progress: The Foundation for Women's Cancer

The 2025 FWC strategic plan sets the course to improve outcomes for all patients.

Lead 3

Shaping the Next Generation of Leaders

The SGO LEAD 2.0 Summit, prior to the SGO 2025 Annual Meeting on Women’s Cancer, provided an opportunity for mentees to meet in person and expand their learning experience.

A Potential Second-Line Treatment for Cervical Cancer

Combining BVAC-C and durvalumab in recurrent or metastatic cervical cancer.

Tamar Gootzen, MD

An Alternative Approach to Preventing Ovarian Cancer?

The ongoing TUBA-WISP II study could point the way to a new preventive approach for those at high risk for tubo-ovarian cancer.

Fang Jiang, MD, PhD

Changing the Course for First-Line, Low-Risk Gestational Trophoblastic Neoplasia

Study marks first substantial cohort enrollment and analysis of this nature.

Angela Nolin, MD

It’s Time to Change the Diagnosis Protocol for Endometrial Cancer

Study finds that patients in certain ethnic groups aren’t always getting the timely diagnosis they need.

Matthew A. Powell, MD

Tricky But Treatable

Pembrolizumab alone and with olaparib offer winning combination in treatment of advanced ovarian cancer.

Kathleen N. Moore, MD

Durvalumab Plus Carboplatin and Paclitaxel Delivers One-Two Punch for Endometrial Cancer Treatment

Trial evaluates frequency of different biomarkers and distribution of histological subtypes.

Welcome video

Watch: Welcome to Seattle

headshots of the program chairs

Masterclasses and Hands-On Learning Set the Pace for SGO 2025

Amanda Nickles Fader, MD

Q&A With SGO President Amanda Nickles Fader, MD

convention attendee using an iPad

Get the SGO 2025 Mobile App

Dr. Brewster with docs

Fund the Future. Honor a Legacy

Invited Speaker: Gretchen Schwarze

Invited Speaker: Monica Bertagnolli

Invited Speaker: Jonathan Perlin

Author Liz Wiseman to Speak at Presidential Session

Register now

Register Now for the SGO 2025 Annual Meeting on Women’s Cancer

CC arch in Seattle

Housing and Travel for SGO 2025 Annual Meeting on Women’s Cancer